These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21826023)

  • 41. Biological properties of aldosterone. Physiological and pathological implications.
    ROSS EJ
    Br Med Bull; 1962 May; 18():164-9. PubMed ID: 14494167
    [No Abstract]   [Full Text] [Related]  

  • 42. [Additional methods of assessment of immune status].
    Zemskov AM; Zemskov VM
    Klin Lab Diagn; 1994; (3):34-5. PubMed ID: 7921816
    [No Abstract]   [Full Text] [Related]  

  • 43. Immune system alterations by aldosterone during hypertension: from clinical observations to genomic and non-genomic mechanisms leading to vascular damage.
    Muñoz-Durango N; Barake MF; Letelier NA; Campino C; Fardella CE; Kalergis AM
    Curr Mol Med; 2013 Jul; 13(6):1035-46. PubMed ID: 23590758
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exploring the pathogenesis linking primary aldosteronism and obstructive sleep apnea via bioinformatic analysis.
    Zhao L; Dong Y; Wei Y; Li J; Zhang S
    Medicine (Baltimore); 2024 Sep; 103(36):e39468. PubMed ID: 39252231
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primary hyperaldosteronism associated with type 3 autoimmune polyendocrine syndrome: A rare case report.
    Li X; Gu L; Zhao W; Xiao J; Cao C
    Clin Case Rep; 2024 Aug; 12(8):e9256. PubMed ID: 39104740
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Mineralocorticoid Receptor on Smooth Muscle Cells Promotes Tacrolimus-Induced Renal Injury in Mice.
    Figueroa SM; Bertocchio JP; Nakamura T; El-Moghrabi S; Jaisser F; Amador CA
    Pharmaceutics; 2023 Apr; 15(5):. PubMed ID: 37242615
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Finerenone, a Non-Steroidal Mineralocorticoid Receptor Antagonist, Reduces Vascular Injury and Increases Regulatory T-Cells: Studies in Rodents with Diabetic and Neovascular Retinopathy.
    Jerome JR; Deliyanti D; Suphapimol V; Kolkhof P; Wilkinson-Berka JL
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768656
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Divergent Characteristics of T-Cell Receptor Repertoire Between Essential Hypertension and Aldosterone-Producing Adenoma.
    Chang CM; Peng KY; Chan CK; Lin YF; Liao HW; Chang JG; Wu MS; Wu VC; Chang WC
    Front Immunol; 2022; 13():853403. PubMed ID: 35619691
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of the innate and adaptive immune responses in the pathogenesis of systemic lupus erythematosus.
    Bolouri N; Akhtari M; Farhadi E; Mansouri R; Faezi ST; Jamshidi A; Mahmoudi M
    Inflamm Res; 2022 Jun; 71(5-6):537-554. PubMed ID: 35298669
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glucocorticoid and mineralocorticoid receptor expression in critical illness: A narrative review.
    Vassiliou AG; Athanasiou N; Vassiliadi DA; Jahaj E; Keskinidou C; Kotanidou A; Dimopoulou I
    World J Crit Care Med; 2021 Jul; 10(4):102-111. PubMed ID: 34316445
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional Characteristic and Significance of Aldosterone-Producing Cell Clusters in Primary Aldosteronism and Age-Related Hypertension.
    Pauzi FA; Azizan EA
    Front Endocrinol (Lausanne); 2021; 12():631848. PubMed ID: 33763031
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabolic Syndrome and COVID 19: Endocrine-Immune-Vascular Interactions Shapes Clinical Course.
    Bansal R; Gubbi S; Muniyappa R
    Endocrinology; 2020 Oct; 161(10):. PubMed ID: 32603424
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Impact of Glucocorticoid Co-Secretion in Primary Aldosteronism on Thyroid Autoantibody Titers During the Course of Disease.
    Handgriff L; Adolf C; Heinrich DA; Braun L; Nirschl N; Sturm L; Ladurner R; Ricke J; Seidensticker M; Bidlingmaier M; Reincke M
    Horm Metab Res; 2020 Jun; 52(6):404-411. PubMed ID: 32403151
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Potential Role of Aldosterone-Producing Cell Clusters in Adrenal Disease.
    Lim JS; Rainey WE
    Horm Metab Res; 2020 Jun; 52(6):427-434. PubMed ID: 32227317
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aldosterone in Gynecology and Its Involvement on the Risk of Hypertension in Pregnancy.
    Sabbadin C; Andrisani A; Ambrosini G; Bordin L; Donà G; Manso J; Ceccato F; Scaroni C; Armanini D
    Front Endocrinol (Lausanne); 2019; 10():575. PubMed ID: 31507531
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk of sepsis in patients with primary aldosteronism.
    Chan CK; Hu YH; Chen L; Chang CC; Lin YF; Lai TS; Huang KH; Lin YH; Wu VC; Wu KD;
    Crit Care; 2018 Nov; 22(1):313. PubMed ID: 30463626
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of Papillary Thyroid Carcinoma with Primary Aldosteronism.
    Nakamura S; Ishimori M; Yamakita N
    Intern Med; 2019 Feb; 58(4):497-504. PubMed ID: 30333389
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adrenocortical incidentalomas and bone: from molecular insights to clinical perspectives.
    Altieri B; Muscogiuri G; Paschou SA; Vryonidou A; Della Casa S; Pontecorvi A; Fassnacht M; Ronchi CL; Newell-Price J
    Endocrine; 2018 Dec; 62(3):506-516. PubMed ID: 30073456
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Coexistence of Primary Hyperaldosteronism and Graves' Disease, a Rare Combination of Endocrine Disorders: Is It beyond a Coincidence-A Case Report and Review of the Literature.
    Gunatilake SSC; Bulugahapitiya U
    Case Rep Endocrinol; 2017; 2017():4050458. PubMed ID: 29214084
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Urinary Exosomes and Their Cargo: Potential Biomarkers for Mineralocorticoid Arterial Hypertension?
    Barros ER; Carvajal CA
    Front Endocrinol (Lausanne); 2017; 8():230. PubMed ID: 28951728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.